ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

STX Shield Therapeutics Plc

1.95
0.00 (0.00%)
Last Updated: 08:00:09
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.95 1.90 2.00 1.95 1.95 1.95 268,538 08:00:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.37 15.12M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.95p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £15.12 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.37.

Shield Therapeutics Share Discussion Threads

Showing 22676 to 22700 of 23400 messages
Chat Pages: Latest  912  911  910  909  908  907  906  905  904  903  902  901  Older
DateSubjectAuthorDiscuss
07/12/2023
09:23
This update covers US only so Europe & US should also be improving ,Canada & South Korea should be on stream very soon & the elusive milestone from China may finally arrive -apart from the possibility of royalties from there .
Hoping for strong recovery next year & an acceptable bid relieving the stale bulls amongst us of the burden of having ever bought here in the first place !

base7
07/12/2023
08:58
eringael7 Dec '23 - 08:43 - 13208 of 13211
0 0 0
Really don’t get the incessant selling, very few in profit - can’t see Shorters still messing about too much who knows
________

a Fund has been selling in the background for a considerable amount of time - not sure if it's Premier Miton or Jupiter but they want out before year end no doubt.

eventually we'll find out who it is - they'll likely be done after today given the buying support and liquidity

Regardless, the key takeaway from the update is the GTN up to $148 already.

bodes well for Q4 and getting it up to $200+ into 2024

the update end January should hopefully confirm all looking a lot better now as GM indicates things are getting back to "original Guidance"

gla

tripletop1
07/12/2023
08:56
This happens a lot.
siggs44
07/12/2023
08:51
My buy just gone through as a sell. How many others?
rustyke1
07/12/2023
08:50
Most of these trades shown as sells are in fact buys.MM's have a lot of stock to get rid of and once this stock is cleared it will rise towards 8p.
z1co
07/12/2023
08:48
Many of the trades just above 6.7p are buys.
parob
07/12/2023
08:43
Really don't get the incessant selling, very few in profit - can't see Shorters still messing about too much who knows
eringael
07/12/2023
08:41
Now 50d ma past stay above 6.6 to break upwards from 2 month range
chester9
07/12/2023
08:29
This is starting to look good. About time. A big question still remains about the competence and integrity of Shield top management.
luckygit
07/12/2023
08:27
Mms corrupt as F@k keep price down and depressed. Should go to at least 8p after the last dilution will not hit 12p .
goforgold1
07/12/2023
08:27
Perhaps Chairman had asked for some extra time to get his cash together :)
chester9
07/12/2023
08:22
Prime takeover target with this sort of growth and price increase.
parob
07/12/2023
08:17
New CFO making his mark? Annualised revenue now $16.4m, which is looking better.
weatherman
07/12/2023
08:14
The confusing aspect and does he know what’s actually happening Greg Madison.In is presentation with the last insider backed funding round stated he didn’t see any increase in the Nett selling price until 2024 then a couple of months later 24% increase.
Clearly he doesn’t have a clue what’s actually hapening

best1467
07/12/2023
08:13
Surprised to get such a late Q3 statement. The 76% quarterly rise is a tick below what we'd been told but is still excellent obviously. The critical thing for me is the big jump in NTG to $148, better than I'd expected. If it can jump further to $160+ next quarter then we're off to the races!
cyberbub
07/12/2023
08:13
Still much more to do and there are oodles of 6p shares to clear. Going to take a while. But better trajectory.
purchaseatthetop
07/12/2023
08:11
Bought some at the open after that impressive update
z1co
07/12/2023
07:59
Should be a deep blue day!
siggs44
07/12/2023
07:49
That $148 is much much better.
purchaseatthetop
07/12/2023
07:49
Fantastic news!
the imperialist
07/12/2023
07:49
Yes and I’m sure that will continue to improve.

Let’s hope we can break this trading range on the back of the update.

parob
07/12/2023
07:43
Nett selling price Q3 $148 is the standout
best1467
07/12/2023
07:27
Margins increasing 24% but much work on this to do. Greg explained this was typical on the journey.
chester9
07/12/2023
07:27
Nice growth. They maybe start telling us prescription numbers quarterly..
bagpuss67
07/12/2023
07:24
Good update
bigjock36
Chat Pages: Latest  912  911  910  909  908  907  906  905  904  903  902  901  Older